Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancer × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 7 Lymphoma, Large B-Cell, Diffuse 6 Osteosarcoma 4 Lymphoma 4 Wilms Tumor 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Neoplasms 3 Carcinoma, Renal Cell 3 Retinoblastoma 2 Optic Nerve Glioma 2 Neuroblastoma 2 Melanoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Carcinoma, Hepatocellular 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocytopenia 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1

Interventions

Nivolumab 6 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Paclitaxel 4 Docetaxel 4 Pemetrexed 3 Ipilimumab 3 Erlotinib Hydrochloride 3 Carboplatin 3 ARRY-334543 3 apatinib 2 abemaciclib 2 Vorinostat 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Everolimus 2 Chlorogenic Acid 2 Cetuximab 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 vistusertib 1 trametinib 1 tislelizumab 1 tilsotolimod 1 sargramostim 1 regorafenib 1 ralimetinib 1 prexasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡